MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Pulse Biosciences Cash Conversion Cycle 2011-2026 | PLSE
Annual Cash Conversion Cycle Pulse Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.51 K | - | - | 36.5 | 119 | -1.34 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 119 | -1.51 K | -674 |
Quarterly Cash Conversion Cycle Pulse Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -918 | - | - | - | - | - | - | - | - | - | - | - | 25.3 | 342 | 356 | - | 96.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 356 | -918 | -19.7 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M |  USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
134 | $ 76.07 | 0.38 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
404 | $ 10.84 | -1.35 % | $ 26.3 M | USA |
 |
The Cooper Companies
COO
|
210 | $ 64.8 | 0.59 % | $ 12.9 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
iRhythm Technologies
IRTC
|
59.8 | $ 126.86 | 3.69 % | $ 4.06 B | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Repro Med Systems
KRMD
|
83.1 | $ 4.06 | 2.48 % | $ 188 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
Microbot Medical
MBOT
|
-52.9 | $ 2.17 | -1.14 % | $ 99.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
533 | $ 0.32 | 0.87 % | $ 26.3 M | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 61.2 | 2.03 % | $ 3.08 B | USA |
 |
electroCore
ECOR
|
-39.3 | $ 6.17 | -0.08 % | $ 52.3 K | USA |
 |
ICU Medical
ICUI
|
146 | $ 123.61 | -0.97 % | $ 3.05 B | USA |
 |
Envista Holdings Corporation
NVST
|
77.3 | $ 26.77 | -0.09 % | $ 4.5 B | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
203 | $ 475.23 | -1.45 % | $ 170 B | USA |
 |
West Pharmaceutical Services
WST
|
97.3 | $ 302.36 | -1.15 % | $ 21.9 B | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 122.18 | 0.43 % | $ 5.92 B | USA |
 |
STERIS plc
STE
|
112 | $ 221.81 | 0.03 % | $ 21.9 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 178.63 | - | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
24.9 | $ 10.77 | 4.16 % | $ 222 M | USA |
 |
Teleflex Incorporated
TFX
|
285 | $ 136.01 | -0.4 % | $ 6.07 B | USA |
 |
Merit Medical Systems
MMSI
|
167 | $ 67.5 | -1.58 % | $ 3.99 B | USA |
 |
Utah Medical Products
UTMD
|
321 | $ 67.0 | -0.25 % | $ 217 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
66 | $ 11.9 | -0.08 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
203 | $ 0.64 | -2.11 % | $ 19.2 M | USA |
 |
Pro-Dex
PDEX
|
193 | $ 51.5 | -1.15 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
29 | $ 115.56 | 1.86 % | $ 2.62 B | USA |
 |
Predictive Oncology
POAI
|
-7.15 K | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
26 | $ 26.37 | 2.73 % | $ 1.31 B | USA |
 |
BioLife Solutions
BLFS
|
37.9 | $ 21.55 | 0.8 % | $ 993 M | USA |
 |
Stereotaxis
STXS
|
143 | $ 1.94 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
106 | $ 18.29 | 0.72 % | $ 9.38 B | USA |
 |
ResMed
RMD
|
167 | $ 221.05 | 0.61 % | $ 32.3 B | USA |
 |
AtriCure
ATRC
|
185 | $ 29.32 | 0.14 % | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
243 | $ 6.69 | -2.48 % | $ 297 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
124 | $ 11.13 | 0.27 % | $ 455 M | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 151.85 | -0.18 % | $ 43.7 B | USA |
 |
Nephros
NEPH
|
161 | $ 3.01 | 4.88 % | $ 31.3 M | USA |
 |
OraSure Technologies
OSUR
|
211 | $ 2.96 | -1.5 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
272 | $ 118.28 | 0.58 % | $ 6.59 M | USA |